FDA Clearance Tracker · P100047-S235
HeartWare HVAD System
Last checked: Nov 20, 2026Latest source record: Apr 7, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 7, 2026
Approved
Time to decision
137 days
Received Nov 21, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for changes to the HVAD Battery Pack including: 1) adjusting the State of Charge (SOC) to no greater than 30%, 2) enabling the Sleep Mode feature before packaging and shipping, 3) adding a new ICAO Packing Instruction (PI) 966 for UN3481, 4) adding a Sleep Mode Battery Charger/Discharger as a new manufacturing process equipment, and 5) discontinuing the HVAD Batteries recharge process.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.